Volume 35, Issue 6 pp. 682-694
REVIEW

Advances in diagnostic liquid-based cytology

Hideyuki Abe

Hideyuki Abe

Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan

Search for more papers by this author
Akihiko Kawahara

Corresponding Author

Akihiko Kawahara

Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan

Correspondence

Akihiko Kawahara, Department of Diagnostic Pathology, Kurume University Hospital, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.

Email: [email protected]

Search for more papers by this author
Jun Akiba

Jun Akiba

Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan

Search for more papers by this author
Rin Yamaguchi

Rin Yamaguchi

Department of Diagnostic Pathology, Nagasaki University Hospital, Nagasaki, Japan

Search for more papers by this author
First published: 04 June 2024
Citations: 2

Abstract

Liquid-based cytology (LBC) has changed the landscape of gynaecological cytology. A growing demand exists for LBC in diagnostic cytology, particularly for ancillary testing, such as immunocytochemistry and molecular testing. Ancillary testing solely based on conventional preparation (CP) methods remains challenging. Recently, the increased demand for specialist testing and minimally invasive techniques, such as endoscopic ultrasonography fine-needle aspiration, to obtain cellular samples has led to an increasing demand for ancillary testing on cytology LBC supernatant, slides and cell block (CB). This facilitates the diagnosis and prognosis in cytology samples enabling personalized treatment. An understanding of the history and future prospects of LBC is crucial for its application in routine diagnostics by cytopathologists and cytotechnologists. In this review, we initiated an internet search using the keyword ‘liquid-based cytology’, and we conducted a literature review to discuss the usefulness of combined diagnosis of LBC and CP, immunocytochemistry and molecular testing and assessed the quality of nucleic acids in diagnostic LBC. High-quality and cell-rich diagnostic LBC surpassed the CP method alone in terms of reliability and versatility of ancillary testing in cytological diagnosis. Conclusively, diagnostic LBC lends itself to various new technologies and is expected to continue evolving with innovations in the future.

Graphical Abstract

Cancer is a disease with highly diverse forms and characteristics. Diagnostic LBC is an essential tool for understanding this diversity of cancer.

This study aims to review the literature on diagnostic liquid-based cytology. Additionally, it provides an overview of the cytological applications of non-gynaecological liquid-based cytology.

CONFLICT OF INTEREST STATEMENT

The authors made no disclosures.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.